Emergent BioSolutions Inc. (0IGA.L) LSE

13.81

+1.748(+14.49%)

Updated at January 15 08:07AM

Currency In USD

Valuation

Market Cap506.68M
Enterprise Value1.08B
P/E Ratio8.79
PEG Ratio-0.19
Price/Sales Ratio0.86
Price/Book Ratio1.15
Enterprise/Revenue1.39
Enterprise/EBITDA5.07

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterSeptember 30, 2025

Profitability

Profit Margin0.1
Operating Margin0.15

Management Effectiveness

Return On Assets0.05
Return On Equity0.14

Income Statement

Revenue1.04B
Revenue/Share14.83
Gross Profit375.4M
EBITDA53.4M
Net Income-190.6M
Diluted EPS-3.6

Balance Sheet

Total Cash245.5M
Total Cash/Share4.61
Total Debt663.1M
Total Debt/Equity1.14
Current Ratio5.76
Book Value Per Share10.95

Price History

52-Week Change47.7
52-Week High13.81
52-Week Low1.48
Moving Average 50 Days2.24
Moving Average 200 Days4.13

Statistics

Average Volume19,429
Shares Outstanding53.98M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split FactorN/A
Last Split DateN/A